NKEMarch 26, 2026 at 4:34 PM UTCConsumer Durables & Apparel

Nike's Turnaround Optimism Confronts Persistent Operational Headwinds

Read source article

What happened

A Seeking Alpha article from March 26, 2026, claims Nike's turnaround is already working, highlighting a Q2 FY2026 EPS beat and 8% wholesale revenue growth. However, the latest DeepValue master report maintains a 'WAIT' rating, citing a 300 bps YoY gross margin decline to 40.6% driven by tariffs and inventory liquidation. Operational data shows a mixed picture: while wholesale revenue rose 8%, Nike Direct fell 8%, and inventories decreased 3% YoY to $7.7 billion, but this hasn't stemmed margin pressure. Key risks include a $300 million pre-tax restructuring charge in Q3 FY26, ongoing weakness in Greater China, and the need for proof of full-price mix recovery by second-half FY26. Thus, the article's bullish narrative overlooks the fundamental challenges that keep the turnaround in a precarious, unproven state.

Implication

The Q2 EPS beat and wholesale growth are positive signs but must be weighed against persistent gross margin compression and upcoming restructuring charges. Nike's high valuation at P/E 32.1 and EV/EBITDA 18.9 demands a swift profitability pivot that remains uncertain given tariff impacts and competitive pressures. Management's focus on exiting liquidation channels and improving full-price mix needs to materialize in second-half FY26 to support earnings growth and justify the stock price. Downside risks include potential additional restructuring actions and sustained China declines, which could trigger further de-rating. Therefore, aligning with DeepValue's 'WAIT' rating is prudent, with close monitoring of upcoming quarterly results for tangible progress.

Thesis delta

The Seeking Alpha article does not materially shift the investment thesis from the DeepValue report, which already incorporates Q2 FY2026 data. Nike's turnaround success still hinges on margin improvement and China recovery, with the next 2-3 quarters critical for validating management's promises. Investors should remain patient, as premature optimism could overlook underlying operational strains.

Confidence

Medium